Rosalind Advisors, Inc. Q4 2024 Filing

Filed February 11, 2025

Portfolio Value

$195.6B

Holdings

40

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (40 positions)

#StockSharesValue% PortfolioType
1
DCTHDELCATH SYS INC
2,650,389$31.9B16.32%
2
MYOMYOMO INC
2,998,945$19.3B9.87%
3
MDWDMEDIWOUND LTD
628,050$11.2B5.72%
4
CMRXEURCHIMERIX INC
3,050,000$10.6B5.43%
5
XERSXERIS BIOPHARMA HOLDINGS INC
3,104,995$10.5B5.38%
6
ABEOABEONA THERAPEUTICS INC
1,805,390$10.1B5.14%
7
OCULOCULAR THERAPEUTIX INC
1,128,700$9.6B4.93%
8
URGNUROGEN PHARMA LTD
870,000$9.3B4.74%
9
YB4PSAVARA INC
2,654,944$8.2B4.17%
10
FRXFENNEC PHARMACEUTICALS INC
1,259,876$8.0B4.07%
11
HELPCYBIN INC
810,918$7.2B3.66%
12
VRNAVERONA PHARMA PLC
150,000$7.0B3.56%
13
NSPRINSPIREMD INC
2,495,783$6.6B3.36%
14
0OPOPTINOSE INC
876,996$5.9B3.00%
15
PRNPROFOUND MED CORP
692,185$5.2B2.66%
16
VSTMVERASTEM INC
900,000$4.7B2.38%
17
TRVITREVI THERAPEUTICS INC
1,062,500$4.4B2.24%
18
SAVACASSAVA SCIENCES INC
417,400$3.7B1.87%Put
19
REPLREPLIMUNE GROUP INC
260,000$3.1B1.61%
20
PYPDPOLYPID LTD
1,022,521$3.1B1.59%
21
BMEABIOMEA FUSION INC
910,700$2.8B1.41%Put
22
CMPSCOMPASS PATHWAYS PLC
707,625$2.7B1.37%
23
KALVKALVISTA PHARMACEUTICALS INC
303,864$2.6B1.32%
24
ACOGALPHA COGNITION INC
252,753$1.5B0.76%
25
SAVACASSAVA SCIENCES INC
417,400$985.1M0.50%
26
CRMDCORMEDIX INC
183,900$919.5M0.47%Call
27
BFRIBIOFRONTERA INC
811,918$885.0M0.45%
28
KPRXKIORA PHARMACEUTICALS INC
250,555$826.8M0.42%
29
EWTXEDGEWISE THERAPEUTICS INC
237,500$807.5M0.41%Put
30
AQLTISHARES TR
200,000$404.0M0.21%Put
31
QQQINVESCO QQQ TR
100,000$356.0M0.18%Put
32
TLPHTALPHERA INC
613,939$321.8M0.16%
33
LVLNSPDR SER TR
800,000$311.0M0.16%Put
34
NMRANEUMORA THERAPEUTICS INC.
136,600$300.2M0.15%Put
35
LXRXLEXICON PHARMACEUTICALS INC
1,278,900$281.8M0.14%Call
36
OWLTOWLET INC
49,441$220.0M0.11%
37
RLMDRELMADA THERAPEUTICS INC
100,000$95.0M0.05%Put
38
RLMDRELMADA THERAPEUTICS INC
100,000$52.0M0.03%
39
LVLNSPDR SER TR
1,400,000$22.0M0.01%Call
40
CADLCANDEL THERAPEUTICS INC
262,500$480K0.00%Put